Packaging defects in pestiviral NS4A can be compensated by mutations in NS2 and NS3.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 09 2023
Historique:
medline: 29 9 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

The non-structural (NS) proteins of the

Identifiants

pubmed: 37695056
doi: 10.1128/jvi.00572-23
pmc: PMC10537661
doi:

Substances chimiques

Viral Nonstructural Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0057223

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Virol. 2014 Sep;88(18):10970-4
pubmed: 24965468
J Virol. 2015 Nov;89(22):11668-80
pubmed: 26355097
J Virol. 1998 Mar;72(3):2364-72
pubmed: 9499097
J Virol. 1996 Nov;70(11):7851-8
pubmed: 8892907
Nat Rev Microbiol. 2008 Sep;6(9):699-708
pubmed: 18587411
Virology. 1991 Sep;184(1):341-50
pubmed: 1651596
J Virol. 1996 Feb;70(2):1041-9
pubmed: 8551562
J Virol. 1997 Jul;71(7):5312-22
pubmed: 9188600
FEBS Lett. 1995 Aug 28;371(1):9-12
pubmed: 7664891
Nat Biotechnol. 1997 Sep;15(9):871-5
pubmed: 9306402
Virology. 2009 May 10;387(2):331-40
pubmed: 19327808
Virology. 2000 Aug 1;273(2):351-63
pubmed: 10915606
J Virol. 2004 Mar;78(5):2414-25
pubmed: 14963137
J Virol. 2009 Apr;83(7):3268-75
pubmed: 19153239
J Virol. 2004 Oct;78(19):10765-75
pubmed: 15367643
Virology. 2001 May 25;284(1):37-45
pubmed: 11352666
J Virol. 1999 Nov;73(11):9196-205
pubmed: 10516027
PLoS Pathog. 2017 Feb 2;13(2):e1006134
pubmed: 28151973
Virol Sin. 2013 Dec;28(6):326-36
pubmed: 24242363
J Virol. 2019 Feb 19;93(5):
pubmed: 30518653
Virology. 1989 Aug;171(2):637-9
pubmed: 2548336
PLoS Pathog. 2019 Feb 7;15(2):e1007163
pubmed: 30730994
J Gen Virol. 2017 Jan;98(1):2-3
pubmed: 28218572
J Virol. 2017 Oct 13;91(21):
pubmed: 28835495
J Virol. 1995 Mar;69(3):1575-81
pubmed: 7853491
J Gen Virol. 2021 Oct;102(10):
pubmed: 34676824
J Virol. 1997 Jul;71(7):5415-22
pubmed: 9188613
J Gen Virol. 2006 Oct;87(Pt 10):2961-2970
pubmed: 16963755
J Virol. 2005 Jul;79(14):9119-27
pubmed: 15994806
Arch Virol. 2015 Jun;160(6):1435-48
pubmed: 25877822
Virus Res. 1997 May;49(1):101-13
pubmed: 9178501
Nat Struct Mol Biol. 2006 Apr;13(4):372-3
pubmed: 16532006
PLoS Pathog. 2012;8(3):e1002598
pubmed: 22457622
J Virol. 1999 Nov;73(11):9422-32
pubmed: 10516051
J Gen Virol. 1999 May;80 ( Pt 5):1147-1155
pubmed: 10355761
J Virol. 2011 Feb;85(3):1193-204
pubmed: 21047963
J Virol. 1988 Aug;62(8):2823-7
pubmed: 2455820
Am J Vet Res. 1990 Sep;51(9):1388-94
pubmed: 2168687
J Virol. 1995 Jul;69(7):4373-80
pubmed: 7769699
J Virol. 2011 Apr;85(7):3607-20
pubmed: 21270154
J Virol. 2005 Aug;79(15):9746-55
pubmed: 16014936
J Virol. 1999 Apr;73(4):2886-92
pubmed: 10074136
J Virol. 2002 Oct;76(19):9588-99
pubmed: 12208938
Virology. 1993 Mar;193(1):1-10
pubmed: 8382392
FEBS Lett. 1989 Jan 30;243(2):103-14
pubmed: 2645167
J Virol. 2004 Dec;78(23):13072-81
pubmed: 15542659
J Virol. 2007 Sep;81(17):8905-18
pubmed: 17581983
PLoS Pathog. 2010 Jul 01;6:e1000978
pubmed: 20617177
Adv Virus Res. 2015;93:47-160
pubmed: 26111586
Virology. 2007 Sep 1;365(2):376-89
pubmed: 17482232
J Virol. 2015 Apr;89(8):4356-71
pubmed: 25653438
Virology. 1988 Jul;165(1):191-9
pubmed: 2838957
J Virol. 1995 Mar;69(3):1720-6
pubmed: 7853509
J Virol. 1994 Jun;68(6):3753-60
pubmed: 8189513
J Virol. 2022 Aug 10;96(15):e0187421
pubmed: 35867575
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723
J Virol. 2010 Nov;84(21):11523-31
pubmed: 20702631
J Virol. 2014 Jan;88(1):82-98
pubmed: 24131714
J Virol. 1996 Dec;70(12):8606-13
pubmed: 8970985

Auteurs

Jonas Fellenberg (J)

Institute of Virology and Cell Biology, University of Luebeck , Luebeck, Germany.

Danilo Dubrau (D)

Institute of Virology and Cell Biology, University of Luebeck , Luebeck, Germany.

Olaf Isken (O)

Institute of Virology and Cell Biology, University of Luebeck , Luebeck, Germany.

Norbert Tautz (N)

Institute of Virology and Cell Biology, University of Luebeck , Luebeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH